Purpose. We determined the test performance characteristics of four brief post-traumatic stress disorder (PTSD) screening tests in a civilian primary care setting.
Introduction

Overview
The US Preventive Services Task Force (USPSTF) provides evidence-based guidelines for clinical preventive services in primary care. Mental health and substance abuse screening are included. Level A recommendations (strong evidence) include screening adults for tobacco use and cessation counselling. Level B recommendations (fair evidence) include adult and adolescent depression screening (12) (13) (14) (15) (16) (17) (18) years old), adult alcohol abuse screening and adult alcohol abuse counselling. Level I recommendations (insufficient evidence) include childhood depression (7-11 years old) screening, physical abuse or neglect of children, domestic violence, elder abuse, dementia screening in the elderly, illicit drug use and suicide.
Screening test criteria Adult PTSD screening in civilian primary care meets clinical utility standards. First, PTSD is harmful. The National Comorbidity Survey confirmed that PTSD is often a chronic recurrent disorder. 5, 6 Furthermore, PTSD is associated with health issues: health risk behaviours (e.g. smoking, sedentary lifestyle, medical nonadherence), vague physical complaints, chronic medical problems (e.g. diabetes mellitus, COPD), mental health comorbidity (e.g. depression, alcohol abuse) and functional impairment (e.g. relationship instability, underachievement). 7 Second, PTSD is prevalent. Estimates of lifetime PTSD in community samples fall in the 5%-6% range for men and 10%-12% range for women. [5] [6] [7] [8] Within primary care, lifetime PTSD of 6%-36% and current PTSD of 10%-20% have been reported. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Rates vary according to the population being studied, with veteran, urban, female, minority and treatmentseeking samples reporting higher rates of trauma and PTSD. 10, 22 Even in civilian primary care samples, however, rates of current PTSD of 6%-20% are typically reported. 7, [9] [10] [11] 14, 16, 17, 19 Increased rates of somatization and health care utilization by individuals with PTSD have been argued to account for this prevalence in primary care settings. 13 In one study, frequent users of health care services were more than twice as likely to have PTSD than less frequent users. 23 Third, effective treatments are available for PTSD and a number of groups have published evidencebased treatment guidelines. Most PTSD patients who undergo an evidence-based treatment experience symptom and functional improvement. 7 However, available research suggests that many primary care providers fail to identify PTSD or to recommend appropriate treatment. 14, [24] [25] [26] [27] [28] [29] Research to examine the relationship between mental health screening and primary care treatment exists. For example, collaborative care models for identifying and managing depression in primary care involve cooperation between primary care physician, mid-level case manager and mental health specialist. Treatment is regularly adjusted according to an evidence-based algorithm. [30] [31] [32] [33] Work is underway to test the effectiveness of collaborative care for PTSD in primary care. [34] [35] [36] Fourth, effective, efficient and practical PTSD screening methods have recently become available for primary care. However, PTSD screening tests were initially developed with military samples 37, 38 and as primary care PTSD screening research appeared, it remained skewed towards military samples, [39] [40] [41] [42] [43] with some exceptions. [44] [45] [46] While PTSD among military veterans is an important issue, on a numeric basis, more civilians suffer PTSD. 7 As PTSD identification is generally low within civilian primary care settings, validation of PTSD screening tests in a civilian primary care setting is an important research gap addressed by this study. 14, [24] [25] [26] [27] [28] [29] Study focus This study was conducted in a civilian primary care setting. Our goal was to determine test performance characteristics (efficiency, sensitivity, specificity, likelihood ratios and predictive values) of four commonly used PTSD screening tests contrasted to a 'gold standard' PTSD interview (see methods section for specific measures). 37, 39, 45, 46 The ideal PTSD screening test will have good diagnostic efficiency [area under the curve (AUC) >0.80], sensitivity (>80%) (minimal false negatives) and specificity (>80%) (minimal false positives). 2, 3 We consider clinical and research implications of study results in the discussion section.
Methods
Study population
Participants were recruited from the Family Practice Center (FPC) of the Trident/Medical University of South Carolina (MUSC) Family Medicine Residency. The FPC is a resident/faculty physician practice with >30 physician providers. The FPC hosts >5000 annual unique adult visits. The patient population includes a mix of urban, suburban and rural residents. FPC patient demographics (e.g. age, race, education, median household income) roughly match 2008 US Census estimates for the three county catchment area served. 47 Written informed consent was obtained from FPC patients from December 2005 through May 2006. Eligible participants were age >18 years, English speaking, no gross cognitive impairment, medically stable and identified by clinic registration staff at check-in. Clinic nurses were trained to tell eligible patients that the physician wanted to discuss study participation. Physicians were trained to explain the study and obtain written informed consent. Consented patients provided telephone contact information for a later telephone interview.
To promote uniform recruitment, all FPC workers (front desk staff, nurses and physicians) attended a 30-minute training session. Each training session emphasized the nature of the study ('. . . the impact of stressful life events upon patient adjustment . . .') and the importance of uniform recruitment ('. . . to avoid systematic bias, please approach all eligible patients . . .'). The project principal investigator provided twice weekly recruitment reminders to FPC staff throughout study recruitment.
Participation statistics included: written consent (n = 774 out of 3728 unique adult patients during study recruitment; 20.8%), contact of consented patients by telephone (n = 519 of 774; 67.1% of consented patients), completed telephone interviews (n = 411 of Family Practice-an international journal 519 or 79.1% of contacted patients), 53.1% of consented (n = 774) patients and 11.0% of unique adult patients during study recruitment (n = 3728).
Data collection
The Survey Research Unit (SRU) of the Department of Health Administration at MUSC conducted the interviews. SRU staff consists of qualified interviewers, selected based on their abilities to communicate clearly, be patient and understand the survey research process.
The project PI (JRF) conducted two, 1-hour training sessions with the SRU interviewers. The first training session occurred days prior to data collection. The second training session occurred 3 weeks following the initiation of telephone interviews. The training sessions provided instruction on interview administration and scoring.
Our telephone survey addressed: demographics, lifetime traumatic event exposure, mental health symptoms (PTSD and depression) and patient opinions regarding physician questions. The order of the PTSD screening measures (iv) was randomized to remove the influence of test order on the relationship between the PTSD screening measures (iv) and diagnostic interview (i). The full survey instrument is described elsewhere. 48 Measures PTSD screening tests. Four PTSD screening tests were used in this study (17-item PTSD Symptom Checklist or PCL, four-item SPAN, seven-item Breslau scale and four-item Primary Care PTSD or PC-PTSD screen). [37] [38] [39] 43, 45, 46, [49] [50] [51] The response scale for each screening test was the same as in previously published work. To insure temporal uniformity, each PTSD screening test assessed the presence of PTSD symptoms in the past month.
The PTSD Symptom Checklist (PCL) was developed for use with military populations and later adapted for civilian use. 37, 38, 49, 50 For this study, participants rated the frequency of the 17 symptoms within the past month (1 = not at all to 5 = extreme; possible score range of 17-85). A cut-off score of >50 has been considered positive. 37, 38 A lower cut-off score (44-50 range) may be appropriate for some populations. 49, 50 The SPAN is a four-item test (startle, physically upset by reminders, anger and numbness; 0 = not at all distressing to 4 = extremely distressing). For this study, participants rating the intensity of the four symptoms in the past month. The scale development sample included 243 adults from non-primary care samples. The Davidson Trauma Scale was contrasted to a gold standard PTSD diagnostic interview in both an index and a replication sample. 46 A four-item solution was demonstrated and confirmed in these two samples with the following test characteristics: 0.88 diagnostic efficiency, 0.84 sensitivity and 0.91 specificity. Five is the typical cut-score. [46] [47] [48] [49] [50] [51] Breslau et al. 45 developed a seven-item PTSD screening test based on a representative community sample of 2181 adults aged 18-45 years (yes versus no scoring format). For this study, participants rated the presence of each symptom (yes versus no) in the past month. A combination of 'best subset regression analysis' and receiver operating characteristic (ROC) analysis were used to select the seven items that best predicted PTSD. The following test characteristics were reported: 80% sensitivity and 97% specificity (authors did not report diagnostic efficiency in original article). Four is the typical cut-score. 45 The PC-PTSD screen is a four-item test developed with a sample of 188 men and women attending general medicine and women's' health clinics at a Veterans' Administration medical center (yes versus no scoring format). Study participants were asked to rate the presence of each symptom (yes versus no) in the past month. The PC-PTSD is the first brief PTSD screening test to be developed with a primary care sample. The test items represent the four symptom types unique to the PTSD diagnosis based on previous factor analytic studies (re-experiencing, numbing, avoidance and hyperarousal). PC-PTSD scores were compared to an index PTSD diagnosis from the Clinician-Administered PTSD Scale (CAPS). Using a cutoff score of 3, the following test characteristics were determined: 85% diagnostic efficiency, 78% sensitivity and 87% specificity. 39 PTSD diagnostic interview. Past month PTSD symptoms were measured using the CAPS (gold standard). In previous research, trained mental health professionals administered the CAPS. [52] [53] [54] The current study modified this procedure by using experienced SRU telephone interviewers (CAPS-mod = CAPS modified). No modifications were made to the CAPS items or scoring. An additional procedure to insure the validity of CAPS-mod results included the previously mentioned training sessions conducted by the study PI (JRF) who is both a board-certified family physician (MD) and a licensed clinical psychologist (PhD). These sessions included item review and case examples to insure the SRU interviewers would properly administer and code the CAPS-mod.
A current (past month) PTSD diagnosis on the CAPS-mod was considered present based upon criteria that the research team judged consistent with American Psychiatric Association diagnostic criteria from the Diagnostic and Statistical Manual Fourth Edition, Text Revision (DSM-IV-TR). 55 The traumatic event criteria (A1 and A2) was considered to be present when the patient either endorsed at least 1 of 12 lifetime traumatic events from the Trauma Assessment for Adults (TAA) 56 or reported a separate traumatic event as prompted by CAPS-mod questions. Patients had required PTSD symptoms, symptom cooccurrence (>1 month) and self-rated functional impairment (moderately severe or more). [52] [53] [54] Elsewhere, we have reported on PTSD diagnostic concordance between the CAPS-mod and the PTSD Symptom Checklist-Civilian Version (PCL-C). 48 
Data analysis
Descriptive statistics were used to characterize both demographic variables and PTSD diagnosis. We stratified demographic variables and PTSD diagnosis by gender. The chi-square statistic was used to contrast gender differences.
Sensitivity, specificity, percent correctly classified and likelihood ratios were developed for each PTSD screening scale as contrasted to the CAPS-mod diagnostic interview. ROC curves were plotted for the four PTSD screening tests using the STATA commands rocss and rocplot. The STATA command roccomp tested the equality of each ROC curve by comparing areas under the ROC curves using a non-parametric algorithm based on chi-square distribution. 57 ROC curve comparisons were repeated for subsamples based on gender. ROC curves were tested statistically to determine if overall diagnostic accuracy of each PTSD screening test varied by gender.
Results
Sample characteristics
A total of 411 adults completed the study (17.5% men and 82.5% women) (see Table 1 ). This gender distribution is significantly different from the clinic population during study recruitment (n = 3728 unique adult visits; 32.2% male and 67.8% female; chi-square = 10.63, P < 0.001). The racial composition of the sample (65.0% white and 35.0% African American or other) is also statistically different from the clinic population during study recruitment (n = 3728 unique adult visits; 56.0% white and 44.0% African American or other; chi-square = 12.11, P = 0.001). Additional demographic data for the clinic population during study recruitment were not available.
With regard to sample demographics, some differences existed between male and female (P < 0.007). Men were more likely to be white, married and to have a higher household income. There were no significant gender differences with regard to age or education.
PTSD prevalence
Past month, PTSD was common among study participants (n = 132 or 32.1%). Significant gender differences (P < 0.01) existed with 35.8% of women (n = 118) and 20.0% of men (n = 14) qualifying for a past month PTSD diagnosis. When depression was defined as a Patient Health Questionnaire-9 score of >20, there was a 76.5% overlap between PTSD and depression. 58 PTSD screening test characteristics Diagnostic efficiency. The diagnostic ability of a screening test is inferred based on an estimate of area under a calculated ROC curve. Using the CAPS-mod for a gold standard current PTSD diagnosis, we were able to plot one ROC curve for each screening test. Figure 1 presents a comparison of all four ROC curves.
An AUC of at least 0.80 is considered proof of diagnostic efficiency. AUC values were adequate: PCL-C Table 2 presents results of tests for ROC AUC equality. A non-parametric algorithm based on chi-square distribution was used to contrast the obtained AUC values. The PCL-C and PC-PTSD AUC values were equivalent. The SPAN (chi-square = 11.79, P < 0.001) and Breslau (chi-square = 7.51, P < 0.001) scales had lower AUC values (less diagnostic efficiency versus PCL-C and PC-PTSD).
We also examined diagnostic efficiency by gender. Diagnostic efficiency was adequate (AUC>0.80) for both men and women on all four tests. For three of four screening tests, diagnostic efficiency was superior for men (PCL-C chi-square = 9.26, P < 0.002; Breslau chi-square = 3.88, P < 0.05; PC-PTSD chi-square = 9.26, P < 0.002).
Diagnostic characteristics. Additional diagnostic characteristics were calculated for each PTSD screening test. Table 3 presents diagnostic characteristics for the PCL-C. A cut-off score of 43 yielded optimal sensitivity and specificity (>0.80). Consistent with high sensitivity (low false negative rate), the negative predictive value (NPV) was 97% suggesting that a score <43 would allow the physician to confidently conclude that PTSD is unlikely. Conversely, positive predictive value (PPV) was only 36.6% suggesting that a score of >43 did not confirm a PTSD diagnosis. Over 80% were correctly classified.
Gender-specific diagnostic characteristics were also determined for the PCL-C. For men, the ideal cut-off score was 46 (sensitivity% = 85.7, specificity% = 95.3 and correctly classified% = 94.3). For women, the ideal cut-off was 43 (sensitivity% = 78.7, specificity% = 80.6 and correctly classified% = 80.3). Table 4 presents diagnostic characteristics for the SPAN. An optimal cut-off score of 3 yielded subpar sensitivity (75.9%) and specificity (71.6%). Despite lower sensitivity, NPV was still acceptably high (95.9%). The PPV of 25.4% suggests that one in four patients screening positive on the SPAN would subsequently be determined to merit a PTSD diagnosis. Fewer than three-fourths were correctly classified.
A SPAN cut-off score of 3 was optimal for both genders. For men, the following test characteristics emerged: sensitivity% = 88.9, specificity% = 77.8 and correctly classified% = 79.2. For women, the results were sensitivity% = 74.0, specificity% = 71.8% and correctly classified% = 72.3%. Table 5 displays diagnostic characteristics for the Breslau et al. 45 screening scale. The optimal cut-off score of 4 yielded good sensitivity (>80%) but lower specificity (76.4%). NPV remained acceptably high (97.5%). PPV suggested that one-third of adults with positive screening scores would ultimately have a confirmed PTSD diagnosis. About three-fourths were correctly classified. Gender-specific diagnostic characteristics were also examined for the Breslau scale. For both men and women, the optimal cut-off score remained 4. However, the associated test characteristics differed by gender. For men, the cut-off score of 4 yielded the following: sensitivity% = 100.0, specificity% = 78.0 and correctly classified% = 78.1. For women, the cut-off score of 4 yielded the following: sensitivity% = 83.3, specificity% = 76.7 and correctly classified% = 78.1. Table 6 contains diagnostic characteristics for the PC-PTSD. An optimal cut-off score of 3 yielded good sensitivity and specificity (>80%). Similarly, the associated NPV was 97.7%. PPV suggested that over one-third with positive results would actually have PTSD. Over four-fifths were correctly classified.
Gender-specific diagnostic characteristics for the PC-PTSD maintained an optimal cut-off of 3 for both genders. For men, this cut-score yielded the following: sensitivity% = 100.0, specificity% = 87.1 and correctly classified% = 88.7. Results were similar for women (sensitivity% = 83.1, specificity% = 82.6 and correctly classified% = 82.7). 
Discussion
Primary findings
We found a high incidence of past month PTSD (32.1% women and 20.0% men) with substantial depression overlap (76.5%). This PTSD rate is on the higher end, although within range of other studies conducted with primary care samples. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] The PTSD depression overlap is common. [5] [6] [7] [8] 16, 59 Several factors may have impacted the reported PTSD rate. In the obtained sample, women were over-represented and African Americans were underrepresented relative to the overall clinic population during the period of study recruitment. Nevertheless, both women and African Americans are heavily represented in the sample. The clinic physicians may have unintentionally contributed to participation bias based on a known tendency to under identify mental health problems among men, African Americans, younger and healthier patients. 23 Women are exposed to higher levels of sexual victimization, a form of trauma that is particularly associated with PTSD risk. [5] [6] [7] [8] Also, women in general are more willing to report anxious and depressed symptoms. 60 One large sample of African American primary care patients found high lifetime prevalence rates for traumatic events (86%) and PTSD (33%). 10 The way PTSD was measured may have overestimated current PTSD (e.g. use of trained non-mental health professionals to administer the CAPS-mod). However, the concordance of CAPSmod and PCL-C diagnosis (score of >50) for this sample supports criterion validity for the CAPS-mod. 48 One additional methodological issue may have impacted the obtained PTSD rate. We questioned all participants about traumatic events (TAA) and PTSD symptoms (CAPS-mod). 48, 56 This so-called 'nonlinkage' strategy tends to produce somewhat higher (and is it thought more accurate) PTSD rates. Some studies have used a 'linkage' strategy that only asks participants about PTSD symptoms if they report at least one qualifying traumatic event prior to discussion of possible PTSD symptoms. This latter approach relies on the sensitivity of traumatic event assessment, an assumption of questionable accuracy if traumatic event questions are too general or few or otherwise prone to false negative responses. 8, 48, 56 Diagnostic efficiency was adequate for all four tests (AUC >0.80). Non-parametric chi-square results confirmed that the PCL-C (17 items) and PC-PTSD (four items) had equivalent diagnostic ability that was superior to either the SPAN or the Breslau scales. Gender differences in AUC values (men > women) existed for three of four screening tests (PCL-C, Breslau and PC-PTSD). In all cases, even the lower AUC values (for women) were considered adequate (>0.80). Our conclusion is that all four PTSD screening tests were diagnostically adequate for this civilian primary care sample.
The obtained cut-off scores were typical of those obtained in non-primary care samples (PCL-C = 43, SPAN = 3, Breslau = 4 and PC-PTSD = 3). Two of four instruments (PCL-C 17 items and PC-PTSD four items) showed adequate sensitivity (minimizes false negatives) and specificity (minimizes false positives). The PC-PTSD was the best single PTSD screening test for use in civilian primary care (brevity; equivalency to the longer PCL-C in terms of diagnostic efficiency, sensitivity and specificity and >80% correct classification). [37] [38] [39] 43, 45, 46, [49] [50] [51] Implications Clinical implications. Family physicians are experts in identifying and managing chronic physical and mental health conditions. For this reason, the USPSTF provides guidelines that include screening and treatment with regard to both physical and mental health conditions. 1 It is essential to recognize that the USPSTF has >100 recommendations for primary care providers. Limitations in provider resources (e.g. time, knowledge, skills, staff) make adhering to screening and treatment recommendations a daunting challenge. Regarding current findings, the use of a single brief PTSD screening test is merely a starting point for diagnostic evaluation. Challenges will occur. For example, a sensitive screening test (>0.80) will eliminate many (but not all) false negative results. A specific screening test (>0.80) will eliminate many (but not all) false positive test results. The selection of a cutoff score for any screening test results in a trade off between sensitivity and specificity. Accordingly, positive screening results trigger further diagnostic efforts to ascertain the accuracy of the screening test result (including additional PTSD questionnaires and/or diagnostic interview). Providers may become frustrated with either the pace or the amount of time associated with assessment or treatment activities. This provider frustration can become a barrier to PTSD patients being identified (through screening) or being offered appropriate treatments on a sustained basis. 7, 48, 61 We believe that it is essential for primary care providers to think about screening efforts (for PTSD or otherwise) at a global level rather than in terms of individual patient or provider needs. In this regard, two considerations are important. First, a systems-based approach is required. For example, the USPSTF recommends that adults and adolescents (12-18 years old) be screened for depression when '. . . staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment and follow-up'. Screening should reliably lead to the application of evidence-based treatments without placing an undue burden on the provider's time. Second, a populationbased approach is essential. For instance, it has been shown that primary care depression screening is optimally efficient (in terms of time, cost and accuracy) when considered on a per number of patients screened basis (e.g. per 100 or per 1000). By recognizing that the task of efficient screening is to take care of an entire patient population (e.g. all adults attending a particular clinic in one year), it becomes apparent that screening can lead to improvements in important patient outcomes. 62 Focus on an individual provider or patient's needs (e.g. time, individual preference) may result in the misleading conclusion that screening is not worthwhile (e.g. inefficient, inaccurate, not cost effective). The current results lend support to the idea that PTSD screening and treatment protocols for primary care settings may be feasible.
It is premature to call for PTSD screening of all adults in civilian primary care. In fact, some have argued that overuse of the PTSD diagnosis can be harmful (e.g. incorrect diagnosis leading to suboptimal treatment, discouraging resilience by encouraging the expectation that strong psychological reactions to trauma are too often pathological). 63, 64 Consistent with calls for caution, it should be recalled that the current PTSD screening tests had modest positive predictive values meaning that each positive screening result requires further diagnostic effort. Existing primary care PTSD screening research instead appears to favour a case-finding approach that involves the selective screening of adult patients based on known risk factors. This includes patients with prior trauma exposure and those with mental health problems that may be trauma associated, such as depression, anxiety, alcohol abuse and chronic vague somatic complaints. 5, 6, 10, 14, 59, 60, 65 Using a case-finding approach to screening may facilitate the detection of PTSD in those patients most likely to have the disorder without the diagnostic burden of universal screening. Selective screening should maximize PPV by increasing true positive (TP) and decreasing false positive (FP) results (PPV = TP/TP + FP). Puddifoot et al. 66 reported that a single question to anxious adult primary care patients ('Is this something with which you would like help?') greatly enhanced positive predictive value (through a reduction is false positive screening results). Multistage screening is another approach to boost diagnostic accuracy. 62 Evidence-based PTSD management guidelines should be followed with primary care patients to confirm positive screening results. Initial steps should involve diagnostic confirmation by either the physician or the designee. Patients with confirmed PTSD should be offered evidence-based treatments as patients receiving sustained an evidence-based treatment (medications, psychotherapy or both) typically show both symptom reduction and functional improvement. 7 In future years, it is hoped that collaborative care models for PTSD will be more widely available. [30] [31] [32] [33] [34] [35] [36] Research implications. This study is not definitive and requires replication. Nevertheless, the results are important. Study strengths include: civilian primary care sample, experienced survey team and standardized measures. As noted in our introduction, a greater number of civilians than military persons suffer PTSD. 7 It is also true that over half of US soldiers with PTSD leave the military prior to proper identification and treatment. [67] [68] [69] Therefore, research to promote PTSD assessment and treatment within civilian primary care is important. [24] [25] [26] [27] [28] [29] Study weaknesses include: convenience sample (limits generalizability) and participation bias (men and ethnic minorities under-represented). The consistency of the current results with previous military, VA, community and primary care findings supports study validity.
Conclusions
Within a civilian primary care sample, it was determined that PTSD was common (especially for women) and often comorbid with depression. The test characteristics of four adult PTSD screening tests were determined. All tests were diagnostically adequate (AUC >0.80). Two of four tests (PCL-C 17 items and PC-PTSD four items) had optimal sensitivity (>80%; minimizing false negatives) and specificity (>80%; minimizing false positives). The brevity of the PC-PTSD, equivalency to the longer PCL-C, and high degree of decision-making accuracy suggests that the PC-PTSD is the best test for application in civilian primary care settings. Given the psychological and physical morbidity associated with PTSD and the availability of effective treatments, the PC-PTSD may be used in a case-finding approach to screening, in which only patients at high risk for having PTSD are selectively screened.
